Gene Expression Profile Testing in Skin Cancer Prognosis: The Data is Clear – It’s Time to Get On Board

Main Article Content

Darrell S Rigel
Roger I Ceilley
Graham H Litchman
Clay J Cockerell


Gene Expression Profile, Skin Cancer, Melanoma, Melanoma Prognosis, 31-GEP


Abstract not available.


Elmore JG, Elder DE, Barnhill RL, et al. Concordance and Reproducibility of Melanoma Staging According to the 7th vs 8th Edition of the AJCC Cancer Staging Manual. JAMA Netw Open. 2018;1(1):e180083. doi:10.1001/jamanetworkopen.2018.0083

Ferguson PM, Gershenwald JE, Scolyer RA. Staging of Cutaneous Melanoma: Is There Room for Further Improvement? JAMA Netw Open. 2018;1(1):e180086. doi:10.1001/jamanetworkopen.2018.0086

Greenhaw BN, Covington KR, Kurley SJ, Yeniay Y, Cao NA, Plasseraud KM, Cook RW, Hsueh EC, Gastman BR, Wei ML, Molecular risk prediction in cutaneous melanoma: a metaanalysis of the 31-gene expression profile prognostic test in 1,479 patients, Journal of the American Academy of Dermatology (2020),

Litchman G, Prado G, Teplitz R, Rigel DS. A Systematic Review and Meta-Analysis of Gene Expression Profiling for Primary Cutaneous Melanoma Prognosis. SKIN J Cutan Med, 2020 May vol 4(3):221-237. doi: 10.25251/skin.4.3.3

Bax MJ, Johnson TM, Harms PW, Schwartz JL, Zhao L, Fullen DR, Chan MP. Detection of Occult Invasion in Melanoma In Situ. JAMA Dermatol. 2016 Nov 1;152(11):1201-1208. doi: 10.1001/jamadermatol.2016.2668.

Ferris LK, Farberg AS, Middlebrook B, Johnson CE, Lassen N, Oelschlager KM, Maetzold DJ, Cook RW, Rigel DS, Gerami P. Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene
expression profile-based classification. J Am Acad Dermatol. 2017 May;76(5):818-825.e3. doi: 10.1016/j.jaad.2016.11.051.

Vetto JT, Hsueh EC, Gastman BR, Dillon LD, Monzon FA, Cook RW, Keller J, Huang X, Fleming A, Hewgley P, Gerami P, Leachman S, Wayne JD, Berger AC, Fleming MD. Guidance of sentinel lymph node biopsy decisions in patients with T1-T2 melanoma using gene expression profiling. Future Oncol. 2019 Apr;15(11):1207-1217. doi:

Farberg AS, Glazer AM, White R, Rigel DS. Impact of a 31-gene Expression Profiling Test for Cutaneous Melanoma on Dermatologists' Clinical Management Decisions. J Drugs Dermatol. 2017;16(5):428-431.

Landow SM, Gjelsvik A, Weinstock MA. Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013. J Am Acad Dermatol. 2017 Feb;76(2):258-263. doi: 10.1016/j.jaad.2016.10.018. Epub
2016 Nov 22.

Gastman B, Gerami P, Kurley S, Cook R, Leachman S, Vetto J. Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria. J Am Acad Dermatol 2019;80:149-57.

Swetter SM, et. al. NCCN Clinical Practice Guidelines in Oncology: Cutaneous Melanoma. April 9, 2020. National Comprehensive Cancer Network; 2020.

Kovarik C, Chu E, Adamson A. Gene Expression Profile Testing for Thin Melanoma; Evidence to Support Clinical Use Remains Thin. JAMA Dermatol 2020 Online publication.

Mathes T, Pieper D. An algorithm for the classification of study designs to assess diagnostic, prognostic and predictive test accuracy in systematic reviews. Systematic Reviews. 2019 Sep;8(1):226. DOI: 10.1186/s13643-019-1131-4.

Berman, B., Ceilley, R., Cockerell, C., Ferris, L., High, W., Lebwohl, M., Nestor, M., Rosen, T., Litchman, G., Prado, G., Svoboda, R., & Rigel, D. (2019). Appropriate Use Criteria for the Integration of Diagnostic and Prognostic Gene Expression Profile Assays into the Management of Cutaneous Malignant Melanoma: An Expert Panel Consensus-Based Modified Delphi Process Assessment. SKIN The Journal of Cutaneous Medicine, 2019;3(5), 291-306. doi:

Marks, E., Caruso, H., Kurley, S., Ibad, S., Plasseraud, K., Monzon, F., & Cockerell, C. (2019). Establishing an evidence-based decision point for clinical use of the 31-gene expression profile test in cutaneous melanoma. SKIN The Journal of Cutaneous Medicine, 2019;3(4), 239-249. doi:

Wysong A, Newman JG, Covington KR, Kurley SJ, Ibrahim SF, Farberg AS, Bar A, Cleaver NJ, Somani AK, Panther D, Brodland DG, Zitelli J, Toyohara J, Maher IA, Xia Y, Bibee K, Griego R, Rigel DS, Plasseraud KM, Estrada S, Sholl LM, Johnson C, Cook RW, Schmults CD, Arron ST. Validation of a 40-Gene Expression Profile Test to Predict Metastatic Risk in Localized High-Risk Cutaneous Squamous Cell Carcinoma. J Am Acad Dermatol. 2020 Apr 25. pii: S0190-9622(20)30704-0. doi:10.1016/j.jaad.2020.04.088.

Most read articles by the same author(s)

1 2 3 > >>